H. Nomura

发表

Prevalence of gallstone disease in a general population of Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, American journal of epidemiology.

Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C

H. Nomura, H. Ishibashi, Y. Miyagi, 2009, Journal of viral hepatitis.

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

H. Nomura, J. Hayashi, N. Furusyo, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

H. Nomura, H. Ishibashi, Y. Miyagi, 2009, Journal of Gastroenterology.

Efficacy of early retreatment with interferon beta for relapse in patients with genotype Ib chronic hepatitis C.

H. Nomura, S. Kashiwagi, J. Hayashi, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical background of cases showing a positive culture of pleural effusion at Shin-Kokura Hospital over a period of 5 years

H. Nomura, S. Kuboi, 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1

H. Nomura, A. Tsubota, Takeshi Matsui, 2016, Journal of Gastroenterology.

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.

H. Nomura, J. Hayashi, K. Kotoh, 2014, Antiviral research.

Body surface area is an independent factor contributing to the effects of lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of combination antiplatelet therapy and nicardipine for chronic cerebral infarction.

H. Nomura, H. Goto, C. Morita, 1996, Clinical therapeutics.

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2022, Alimentary pharmacology & therapeutics.

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

H. Nomura, J. Hayashi, N. Furusyo, 2018, Alimentary pharmacology & therapeutics.

A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development

H. Nomura, S. Kashiwagi, J. Hayashi, 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The effects of a high dose, short course of interferon on hepatitis C

H. Nomura, T. Maruyama, H. Okubo, 1999, Journal of gastroenterology and hepatology.

Hepatitis C virus-related liver damage is related to cold activation of complement.

H. Nomura, T. Ogo, N. Rikimaru, 1997, Journal of clinical gastroenterology.

Usefulness of HCV-RNA assays in efficacy evaluation of interferon treatment for chronic hepatitis C: Amplicor HCV assay and branched DNA probe assay.

H. Nomura, H. Tada, Y. Kimura, 1997, The Journal of infection.

Predictive factors of a response to interferon therapy in chronic hepatitis C.

H. Nomura, S. Kashiwagi, H. Tada, 1996, Journal of clinical gastroenterology.

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis.

H. Nomura, J. Hayashi, N. Furusyo, 2016, Antiviral research.

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of viral hepatitis.

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

H. Nomura, J. Hayashi, N. Furusyo, 2017, Journal of Gastroenterology.

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

H. Nomura, J. Hayashi, K. Kotoh, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

H. Nomura, J. Hayashi, Hwai I. Yang, 2019, Clinical Infectious Diseases.

An epidemiologic study of effects of alcohol in the liver in hepatitis B surface antigen carriers.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, American journal of epidemiology.

Helicobacter pylori eradication prevents the development of gastric cancer – results of a long-term retrospective study in Japan

H. Nomura, M. Asaka, H. Isomoto, 2006 .

Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.

H. Nomura, M. Asaka, Mototsugu Kato, 2011, Internal medicine.

Hepatitis B virus transmission in nursery schools.

H. Nomura, S. Kashiwagi, J. Hayashi, 1987, American journal of epidemiology.

Transmission of hepatitis B virus among siblings.

H. Nomura, S. Kashiwagi, J. Hayashi, 1984, American journal of epidemiology.

Large‐Scale Survey of Hepatitis B Virus Infection in Families

H. Nomura, S. Kashiwagi, J. Hayashi, 1985, Microbiology and immunology.

Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study

H. Nomura, H. Ishibashi, Kazuhiro Takahashi, 2018, Internal medicine.

Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C

H. Nomura, A. Komori, S. Shimoda, 2018, Clinical Journal of Gastroenterology.

Comparison of perflubutane-enhanced US images of vessels in HCC and those in pathological specimens

H. Nomura, Hidetaka Yamamoto, S. Aishima, 2013 .

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2014, Human Genetics.

Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.

H. Nomura, K. Chayama, N. Izumi, 2015, World journal of hepatology.

Splenomegaly in asymptomatic hepatitis B surface antigen carriers.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, The Journal of infectious diseases.

A nosocomial outbreak of hepatitis C in the general ward

H. Nomura, H. Ishibashi, S. Shimoda, 2010 .

Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus‐related liver cirrhosis: A multicenter retrospective study in Japan

H. Nomura, K. Chayama, N. Izumi, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C.

H. Nomura, H. Tanimoto, N. Yamashita, 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Estimation of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA during PEG-IFN plus ribavirin therapy by HCV genotypes and IL28B genotype

H. Nomura, M. Mizokami, N. Masaki, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy

H. Nomura, M. Mizokami, N. Masaki, 2012, Journal of gastroenterology and hepatology.

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

H. Nomura, J. Hayashi, K. Kotoh, 2013, Alimentary pharmacology & therapeutics.

Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients

H. Nomura, N. Enomoto, M. Kurosaki, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B

H. Nomura, M. Sugiyama, M. Mizokami, 2011, Journal of Clinical Microbiology.

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers

H. Nomura, H. Ikezaki, N. Shimono, 2022, Journal of Infection and Chemotherapy.

Dynamics of anti-Spike IgG antibody level after full BNT162b2 COVID-19 vaccination in health care workers

H. Nomura, J. Hayashi, H. Ikezaki, 2021, medRxiv.

Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real‐world cohort study focusing on chronic kidney disease

H. Nomura, J. Hayashi, N. Furusyo, 2018, Antiviral research.

Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Efficacy and safety of splenectomy in telaprevir‐based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis

H. Nomura, J. Hayashi, Y. Maehara, 2014, Journal of gastroenterology and hepatology.

Recommendation of lamivudine‐to‐entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial

H. Nomura, K. Matsuura, F. Sugauchi, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Tricuspid valve endocarditis in a non-drug addict associated with peliosis hepatis.

H. Nomura, T. Ogo, C. Morita, 1997, Internal medicine.

Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection

H. Nomura, M. Kurosaki, N. Izumi, 2015, Journal of Gastroenterology.

An outbreak of influenza A (H3N2) in a hospital for the elderly with emphasis on pulmonary complications.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, Japanese journal of medicine.

Prevalence of liver abnormalities in the general population of Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1997, Fukuoka igaku zasshi = Hukuoka acta medica.

Effective administration methods and dosages of interferon therapy for chronic hepatitis C.

H. Nomura, H. Tada, M. Higashi, 1996, Clinical therapeutics.

Low overlap between anti‐HCV and anti‐HBc in Japanese

H. Nomura, H. Ohto, A. Ishijima, 1991, Transfusion.

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia

H. Nomura, T. Kawaguchi, M. Sata, 2019, Experimental and therapeutic medicine.

Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, The Journal of infection.

Factors contributing to ribavirin‐induced anemia

H. Nomura, S. Kashiwagi, J. Hayashi, 2004, Journal of gastroenterology and hepatology.

Study of Seroconversion of Antibody to Human T‐Cell Lymphotropic Virus Type‐I in Children of Okinawa, Japan

H. Nomura, S. Kashiwagi, J. Hayashi, 1990, Microbiology and immunology.

Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection.

H. Nomura, J. Hayashi, K. Kotoh, 2015, Internal medicine.

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients

H. Nomura, J. Hayashi, K. Kotoh, 2007, Comparative hepatology.

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

H. Nomura, K. Chayama, N. Izumi, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan

H. Nomura, K. Chayama, N. Izumi, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

A case of post-transfusion hepatitis by an occult HBV carrier

H. Nomura, H. Tanimoto, N. Yamashita, 2013 .

Seroepidemiologic Study of Adult T‐Cell Leukemia Virus (ATLV) and Hepatitis B Virus Infection in Okinawa, Japan

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, Microbiology and immunology.

No significant changes in adult T-cell leukemia virus infection in Okinawa after intervals of 13 and 15 years.

H. Nomura, S. Kashiwagi, J. Hayashi, 1986, Japanese journal of cancer research : Gann.

Marked decrease of hepatitis B virus infection among children in Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1990, International journal of epidemiology.

Low prevalence of antibody to adult T-cell leukemia-associated antigen (anti-ATLA) in hospital personnel.

H. Nomura, S. Kashiwagi, J. Hayashi, 1987, The Kurume medical journal.

Prevalence of immunologic markers of hepatitis A and B infection in hospital personnel in Miyazaki Prefecture, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1985, American journal of epidemiology.

Association between the treatment length and cumulative dose of pegylated interferon alpha‐2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

H. Nomura, J. Hayashi, N. Furusyo, 2008, Journal of gastroenterology and hepatology.

Clinical and microbiological characteristics in cases of positive blood cultures at Shin-Kokura Hospital during a period of 5 years

H. Nomura, S. Kuboi, 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Short‐term interferon‐alfa therapy for acute hepatitis C: A randomized controlled trial

H. Nomura, S. Kashiwagi, J. Hayashi, 2004, Hepatology.

Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, World journal of gastroenterology.

Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, Gastroenterologia Japonica.

Sex‐ and Age‐Specific Prevalences of HBeAg and Anti‐HBe among HBsAg Carriers with or without Liver Function Abnormalities in Okinawa, Japan

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, Microbiology and immunology.

Age‐Specific Prevalence of Hepatitis B e Antigen (HBeAg) and Antibody to HBeAg (Anti‐HBe) among Asymptomatic Hepatitis B Surface Antigen (HBsAg) Carriers in Okinawa and Kyushu, Japan

H. Nomura, S. Kashiwagi, J. Hayashi, 1986, Microbiology and immunology.

Long‐term follow up of peginterferon‐α‐2a treatment of hepatitis B e‐antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies

H. Nomura, Y. Imai, Y. Karino, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2015, World journal of hepatology.

Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C

Yoshiyuki Ueno, Akihiro Matsumoto, Hideyuki Nomura, 2011, Journal of Gastroenterology.

Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C

H. Nomura, K. Chayama, N. Izumi, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.

H. Nomura, J. Hayashi, N. Furusyo, 2006, World journal of gastroenterology.

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2021, Hepatology International.

The rs 8099917 Polymorphism , When Determined by a Suitable Genotyping Method , Is a Better Predictor for Response to Pegylated Alpha Interferon / Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28 B †

H. Nomura, M. Sugiyama, M. Mizokami, 2011 .

Prevalence of IgM anti-HBc among HBsAg carriers in Okinawa, Japan

H. Nomura, J. Hayashi, W. Kajiyama, 1990, Gastroenterologia Japonica.

An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1983, American journal of epidemiology.

Remarkable effectiveness of endoscopic argon plasma coagulation against diffuse antral vascular ectasia

H. Nomura, T. Matsui, T. Nagahama, 2004 .

Hemorrhagic duodenal lipoma managed by endoscopic resection

H. Nomura, T. Matsui, T. Nagahama, 2006, Journal of gastroenterology and hepatology.

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α‐2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of gastroenterology and hepatology.

Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.

H. Nomura, J. Hayashi, N. Furusyo, 2006, World journal of gastroenterology.

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

A short‐term eradication therapy for Helicobacter pylori acute gastritis

H. Nomura, M. Asaka, T. Sugiyama, 2000, Journal of gastroenterology and hepatology.

Intrafamilial transmission of adult T cell leukemia virus.

H. Nomura, S. Kashiwagi, J. Hayashi, 1986, The Journal of infectious diseases.

A case of PBC-AIH overlap syndrome with systemic sclerosis and liver scar

H. Nomura, Hidetaka Yamamoto, Y. Miyagi, 2016 .

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan

H. Nomura, J. Hayashi, N. Furusyo, 2019, BMJ Open.

Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2010, World journal of gastroenterology.

The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.

H. Nomura, H. Ishibashi, Kazuhiro Takahashi, 2013, Hepato-gastroenterology.

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

H. Nomura, H. Yoshiji, M. Matsuda, 2021, Journal of Gastroenterology.

A multicenter survey of re‐treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

H. Nomura, H. Nagano, N. Hayashi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery

H. Nomura, R. Hirakata, O. Okamoto, 1999, Journal of gastroenterology and hepatology.

Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity.

H. Nomura, S. Kashiwagi, J. Hayashi, 1990, The Journal of infectious diseases.

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan

H. Nomura, T. Ohkusa, K. Murakami, 2013, Journal of Gastroenterology.

Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.

H. Nomura, A. Kawano, H. Tanimoto, 2014, Internal medicine.

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy

H. Nomura, K. Matsuura, Takeshi Matsui, 2018, Journal of Gastroenterology.

A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1987, American journal of epidemiology.

Effect of ondansetron hydrochloride on nausea and vomiting after transcatheter arterial embolization in patients with hepatocellular carcinoma

H. Nomura, Akemi Kawasaki, Y. Mizuno, 1997 .

肝性脳症・食後腹痛・胆管障害をきたした肝動静脈瘻の1例

H. Nomura, S. Shimoda, T. Maruyama, 2009 .

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2020, The Journal of infectious diseases.

Efficacy of low dose long‐term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha‐fetoprotein: A pilot study

H. Nomura, Y. Kashiwagi, H. Ishibashi, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

H. Nomura, J. Hayashi, Hwai I. Yang, 2019, Hepatology International.

Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections

H. Nomura, J. Hayashi, K. Akashi, 2013, Hepatitis research and treatment.

Pegylated interferon α‐2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

H. Nomura, J. Hayashi, K. Kotoh, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Prevalence of fatty liver in a general population of Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, Japanese journal of medicine.

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

H. Nomura, J. Hayashi, N. Furusyo, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C

H. Nomura, H. Yoshiji, K. Ikeo, 2016, PloS one.

Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin

H. Nomura, H. Tanimoto, S. Nishiura, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of prolonged treatment following combination with ribavirin and interferon for chronic hepatitis type C: A pilot study.

H. Nomura, S. Kashiwagi, J. Hayashi, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

H. Nomura, J. Hayashi, N. Furusyo, 2020, Cancers.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2015, Human Genetics.

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

H. Nomura, J. Hayashi, Hwai I. Yang, 2020, Hepatology International.

[Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus].

H. Nomura, Y. Kimura, G. Shiraishi, 1994, Fukuoka igaku zasshi = Hukuoka acta medica.

[A case of double liver cancer: hepatocellular carcinoma and combined hepatocellular and mucinous cholangiocarcinoma].

H. Nomura, Hidetaka Yamamoto, H. Tanimoto, 2013, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination

H. Nomura, H. Ikezaki, N. Shimono, 2023, iScience.

[Immunogenicity and safety of hepatitis B virus vaccine].

H. Nomura, S. Kashiwagi, J. Hayashi, 1985, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

B型肝炎ウイルスワクチンHEPTAVAX-B®の免疫原性および安全性について

H. Nomura, S. Kashiwagi, H. Ikematsu, 1985 .

Subtypes of hepatitis B surface antigen in familial clusters of hepatitis B virus carriers.

H. Nomura, S. Kashiwagi, J. Hayashi, 1983, American journal of epidemiology.

Effects of antihyperlipidemic drugs and diet plus exercise therapy in the treatment of patients with moderate hypercholesterolemia.

H. Nomura, Y. Kimura, O. Okamoto, 1996, Clinical therapeutics.

A case of the hepatopathy developed prior to IgG4 related autoimmune pancreatitis

H. Nomura, Hidetaka Yamamoto, H. Miyagawa, 2016 .

A senile case of heart failure associated with hypermagnesemia induced by magnesium‐containing laxative agent

Panayiotis D. Megaloikonomos, H. Nomura, M. Hieda, 2022, Geriatrics & gerontology international.

The effect of plaunotol on stomatitis induced by interferon

H. Nomura, Akemi Kawasaki, Y. Mizuno, 1997 .

[Hypoxemia due to pulmonary tumor microembolisms from a hepatocellular carcinoma: a case report].

H. Nomura, Hidetaka Yamamoto, H. Tanimoto, 2015, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Intrafamilial clustering of anti-ATLA-positive persons.

H. Nomura, S. Kashiwagi, J. Hayashi, 1986, American journal of epidemiology.

An outbreak of Mycoplasma pneumoniae infections in a hospital in Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1985, The Kurume Medical Journal.

The control of hepatitis B virus infection with vaccine in Japanese nursery schools.

H. Nomura, S. Kashiwagi, J. Hayashi, 1987, American journal of epidemiology.

[Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].

H. Nomura, S. Kashiwagi, J. Hayashi, 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Changing pattern of intrafamilial transmission of hepatitis B virus in Okinawa, Japan.

H. Nomura, S. Kashiwagi, J. Hayashi, 1988, American journal of epidemiology.

Pilot study of prolonged interferon-alpha retreatment in chronic hepatitis C patients with genotype 1b.

H. Nomura, S. Kashiwagi, J. Hayashi, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.